000 | 01998 a2200577 4500 | ||
---|---|---|---|
005 | 20250516055750.0 | ||
264 | 0 | _c20120217 | |
008 | 201202s 0 0 eng d | ||
022 | _a1872-6240 | ||
024 | 7 |
_a10.1016/j.brainres.2011.09.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZheng, Li-Fei | |
245 | 0 | 0 |
_aReduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson's disease. _h[electronic resource] |
260 |
_bBrain research _cOct 2011 |
||
300 |
_a59-67 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAcetylcholine |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCholine O-Acetyltransferase _xmetabolism |
650 | 0 | 4 | _aChromatography, High Pressure Liquid |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 |
_aGastric Emptying _xphysiology |
650 | 0 | 4 |
_aGastrointestinal Motility _xdrug effects |
650 | 0 | 4 |
_aGene Expression Regulation, Enzymologic _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMotor Neurons _xdrug effects |
650 | 0 | 4 |
_aOxidopamine _xtoxicity |
650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aStatistics, Nonparametric |
650 | 0 | 4 |
_aStomach Diseases _xetiology |
650 | 0 | 4 |
_aSympatholytics _xtoxicity |
650 | 0 | 4 | _aTandem Mass Spectrometry |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTyrosine 3-Monooxygenase |
650 | 0 | 4 |
_aVagus Nerve _xpathology |
700 | 1 | _aWang, Zhi-Yong | |
700 | 1 | _aLi, Xiao-feng | |
700 | 1 | _aSong, Jin | |
700 | 1 | _aHong, Feng | |
700 | 1 | _aLian, Hui | |
700 | 1 | _aWang, Qian | |
700 | 1 | _aFeng, Xiao-Yan | |
700 | 1 | _aTang, Yuan-yuan | |
700 | 1 | _aZhang, Yue | |
700 | 1 | _aZhu, Jin-Xia | |
773 | 0 |
_tBrain research _gvol. 1420 _gp. 59-67 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2011.09.006 _zAvailable from publisher's website |
999 |
_c21192690 _d21192690 |